Sanofi should hear from the FDA in September about its application for Sarclisa as a first-line therapy for multiple myeloma after the US regulator gave it a priority review. The French pharma group ...
These days, Windows has a moderately robust method for managing the volume across several applications. The only problem is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results